The Burn Glove Trial - Hand Burn Dressing Pilot

July 20, 2016 updated by: Southern Illinois University

The Burn Glove Trial-A Randomized Controlled Trial of Dressings for Partial Thickness Hand Burns

Specific Aim 1: To determine if one of three burn dressings provides a less painful healing experience for partial thickness hand.

Specific Aim 2: To evaluate if one of three dressings provides greater functionality during and after healing of partial thickness hand burns.

Specific Aim 3: To determine if one of three burn dressings promotes aesthetically superior healing results for partial thickness hand burns.

Study Overview

Detailed Description

Various products are on the market and available for use on partial thickness burns to the hand/s. Our current institutional standard of care is to use Xeroform Gauze (Coviden, Mansfield, MA) and Bacitracin Ointment (Fougera, Melville, NY) to promote a moist antibacterial healing environment with the ability to monitor the healing progress daily. However, silver (AG) based dressings that employ nanocrystalline technology with hydrofiber (Aquacel AG burn; ConvaTec, Princeton, NJ) or soft silicone foam (Mepilex AG ; Molnlycke Health Care, Dunstable, United Kingdom) have been well accepted as alternative dressing solutions. These dressings have longer interval times between changes, leading to a reported increase in patient comfort, diminished skin shearing/stripping, and rapid re-epithelialization.

Given the anatomic intricacies, partial thickness burns to the hand present a challenge in dressing selection. Recently, ConvaTec unveiled the Aquacel AG Burn Glove for use on partial thickness hand burns. In line with this idea, our institution has now begun to fashion a novel burn glove out of Mepilex Transfer AG with good success. To date there are no known studies that compare Xeroform/Bacitracin, Aquacel AG burn glove or Mepilex Transfer AG dressing. The goal of this study is to compare these three burn dressings used to treat partial-thickness hand burns and their impact on pain, function, and aesthetic outcomes. We will also explore psychosocial issues related to hand burn dressing changes.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Illinois
      • Springfield, Illinois, United States, 62794-9640
        • Southern Illinois University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 60 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients presenting at Memorial Medical or Southern Illinois University (SIU) Health Care
  • Patients with partial-thickness burn injuries to the dorsum and/or palm of the hand/s that exceeds ½% total body surface area (TBSA) for at least one hand.
  • < 10% TBSA 2nd and 3rd degree burn injuries
  • Initial clinical presentation < 5 days post burn injury

Exclusion Criteria:

  • < ½ % TBSA involving the hand
  • > 10%TBSA burn injuries
  • > 60 years of age
  • < 8 years of age
  • Patients (or parents of minors) without cognitive capacity to comprehend informed consent
  • Presentation > 5 days post-burn injury event
  • Pregnant women
  • Full thickness/3rd degree burns to the dorsal and/or palmer hand/s
  • Exposed vital structures (tendons, nerves, bone, vessels)
  • Uncontrolled Type II Diabetes
  • Type I Diabetes
  • History of Chronic Obstructive Pulmonary Disease
  • Have a known allergy to silver products
  • Signs of infection on initial clinical presentation (presence of purulent drainage, significant cellulitis, and/or fever)
  • Smoke/inhalation injuries requiring ventilation
  • Critically ill patients requiring intensive care

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Aquacel® Ag Burn Glove
Application of Aquacel® Ag Burn Glove burn dressing
burn dressing
Other Names:
  • ConvaTec
Active Comparator: Mepilex® Transfer Ag
Application of Mepilex® Transfer Ag burn dressing
burn dressing
Other Names:
  • Safetac®
  • Molnlycke® Health Care
Active Comparator: Xeroform®/Bacitracin®
Application of Xeroform® burn dressing and Bacitracin® topical antibiotic
antibiotic burn dressing
Other Names:
  • Bacitracin®
  • Xeroform®

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain
Time Frame: baseline to 6 months post-burn injury
pain as measured by the Patient and Provider Scar Assessment Scale
baseline to 6 months post-burn injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain
Time Frame: baseline to 6 months post-burn injury
pain as measured by the Michigan Hand Outcomes Questionnaire (MHQ)
baseline to 6 months post-burn injury
pain
Time Frame: baseline to 6 months post-burn injury
pain as measured by the Disabilities of the Arm, Shoulder and Hand Scale, Quick (QuickDASH)
baseline to 6 months post-burn injury
functionality
Time Frame: baseline to 6 months post-burn injury
functionality as measured by the Michigan Hand Outcomes Questionnaire (MHQ)
baseline to 6 months post-burn injury
functionality
Time Frame: baseline to 6 months post-burn injury
functionality as measured by the Disabilities of the Arm, Shoulder and Hand Scale, Quick (QuickDASH)
baseline to 6 months post-burn injury
aesthetic appearance
Time Frame: baseline to 6 months post-burn injury
scar formation and aesthetic appearance measured using the Vancouver Scar Scale
baseline to 6 months post-burn injury
aesthetic appearance
Time Frame: baseline to 6 months post-burn injury
scar formation and aesthetic appearance measured using the the Patient and Provider Scar Assessment Scale
baseline to 6 months post-burn injury

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
quality of life
Time Frame: baseline to 6 months post-burn injury
quality of life measured by the psychosocial scales: Burn Specific Health Scale (BSHS)
baseline to 6 months post-burn injury
resilience
Time Frame: baseline to 6 months post-burn injury
resilience measured by the Connor-Davidson Resilience Scale (CD-RISC)
baseline to 6 months post-burn injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nada N Berry, MD, Southern Illinois University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2015

Primary Completion (Actual)

July 1, 2016

Study Completion (Actual)

July 1, 2016

Study Registration Dates

First Submitted

July 23, 2014

First Submitted That Met QC Criteria

December 11, 2014

First Posted (Estimate)

December 17, 2014

Study Record Updates

Last Update Posted (Estimate)

July 21, 2016

Last Update Submitted That Met QC Criteria

July 20, 2016

Last Verified

July 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burns

Clinical Trials on Aquacel® Ag Burn Glove

3
Subscribe